SF News Global Supplement News Engine
Regulation

Proposed US Grant Rules Threaten Food Science Innovation and Research Funding

New US government proposals to overhaul federal grant administration could shift research funding from scientific merit to political priorities, impacting food and beverage innovation. Industry bodies flag concerns over independent peer review and research continuity for supplement ingredient development.

Proposed US Grant Rules Threaten Food Science Innovation and Research Funding

Washington D.C., United States — 01 July 2026

Proposed revisions to how the US government awards and manages federal grants are causing significant concern across the food and beverage industry, including the supplement sector. The Office of Management and Budget's (OMB) initiative, published on 29 May 2026, aims to modernise the Uniform Guidance, the comprehensive framework for federal financial assistance. While proponents argue the changes will enhance accountability and reduce fraud, critics, including the Institute of Food Technologists (IFT), warn of detrimental impacts on research independence and innovation.

The current consultation period for these changes closes on 13 July 2026, with a final rule anticipated by 1 October 2026. The 400-plus-page proposal introduces greater oversight by senior political appointees over discretionary grant awards and expands federal agencies' authority to suspend or terminate grants. Furthermore, it seeks to reshape how peer review influences funding decisions, a critical component for robust scientific research in areas such as novel ingredient development and safety assessments.

Many supplement companies do not directly receive federal grants but rely heavily on innovations stemming from university and government-funded research. For instance, new functional ingredients, processing techniques, or analytical methods often originate from these collaborative projects. According to IFT Chief Science and Technology Officer Brendan Niemira, the proposed rules, if implemented without safeguards, could 'erode US leadership' in scientific research. He highlights that shifting research funding decisions from scientific merit to political priorities could undermine academic-industry partnerships crucial for supplement innovation, risking delays in bring new, evidence-backed ingredients to market.

Another significant concern is the potential impact on scholarly publishing and research dissemination. Niemira suggests that if publication costs or open-access fees become harder to fund through grants, researchers could face barriers to sharing findings. This could reduce the public availability of critical data concerning ingredient safety, efficacy, and application, directly affecting brand owners' ability to formulate with confidence and meet substantiation requirements. A coalition of scientific groups, including the American Association for the Advancement of Science, has requested an extension to the 45-day comment period, citing the extensive scope and potential repercussions of the proposed changes.

What this means for United States

US-based supplement manufacturers and brand owners should anticipate potential slowdowns in novel ingredient development and increased due diligence requirements for sourcing. Lead times for new ingredient commercialisation, previously benefiting from publicly funded foundational research, may expand. Regulatory teams will need closer engagement with industry associations to monitor shifts in government research priorities, which could influence the availability of evidence for specific health claims. Procurement leads should prepare for potential supply chain disruptions if changes impact key academic or government research partners. Brand owners aiming for competitive advantage through science-backed formulations must re-evaluate current and future R&D strategies, considering reduced federal support for independent research.

While an immediate operational impact on the supplement industry is not expected, the final rules, due later this year, will shape the environment for food and agricultural research for years to come. Businesses integrated into this ecosystem via research partnerships or supply chain projects should prepare for increased scrutiny and potential changes to grant administration processes. This could necessitate adjusting internal R&D investment strategies to compensate for reduced external funding.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.